» Authors » Pierre Eid

Pierre Eid

Explore the profile of Pierre Eid including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 27
Citations 1221
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Devocelle A, Lecru L, Francois H, Desterke C, Gallerne C, Eid P, et al.
Int J Cell Biol . 2019 Jul; 2019:9151394. PMID: 31360169
Renal tubulointerstitial fibrosis is the final common pathway in end-stage renal disease and is characterized by aberrant accumulation of extracellular matrix (ECM) components secreted by myofibroblasts. Tubular type 2 EMT,...
2.
Hatem E, Azzi S, El Banna N, He T, Heneman-Masurel A, Vernis L, et al.
J Natl Cancer Inst . 2019 Feb; 111(6):597-608. PMID: 30779852
Background: Cancer cells from different origins exhibit various basal redox statuses and thus respond differently to intrinsic or extrinsic oxidative stress. These intricate characteristics condition the success of redox-based anticancer...
3.
Hatem E, Azzi S, El Banna N, He T, Heneman-Masurel A, Vernis L, et al.
J Natl Cancer Inst . 2018 Nov; PMID: 30462268
Background: Cancer cells from different origins exhibit various basal redox statuses and thus respond differently to intrinsic or extrinsic oxidative stress. These intricate characteristics condition the success of redox-based anticancer...
4.
Prola A, Pires Da Silva J, Guilbert A, Lecru L, Piquereau J, Ribeiro M, et al.
Cell Death Differ . 2016 Dec; 24(2):343-356. PMID: 27911441
Over the past decade, endoplasmic reticulum (ER) stress has emerged as an important mechanism involved in the pathogenesis of cardiovascular diseases including heart failure. Cardiac therapy based on ER stress...
5.
Le Coz V, Zhu C, Devocelle A, Vazquez A, Boucheix C, Azzi S, et al.
Oncotarget . 2016 Oct; 7(50):82511-82527. PMID: 27764776
Melanoma is a particularly virulent human cancer, due to its resistance to conventional treatments and high frequency of metastasis. Melanomas contain a fraction of cells, the melanoma-initiating cells (MICs), responsible...
6.
Hasmim M, Bruno S, Azzi S, Gallerne C, Michel J, Chiabotto G, et al.
Oncotarget . 2015 Nov; 7(13):15507-24. PMID: 26551931
As rapidly developing patient-derived xenografts (PDX) could represent potential sources of cancer stem cells (CSC), we selected and characterized non-cultured PDX cell suspensions from four different renal carcinomas (RCC). Only...
7.
Azzi S, Gallerne C, Romei C, Le Coz V, Gangemi R, Khawam K, et al.
Neoplasia . 2015 Jul; 17(6):509-17. PMID: 26152359
Intrarenal interleukin-15 (IL-15) participates to renal pathophysiology, but the role of its different membrane-bound isoforms remains to be elucidated. In this study, we reassess the biology of membrane-bound IL-15 (mb-IL-15)...
8.
Giron-Michel J, Azzi S, Ferrini S, Chouaib S, Camussi G, Eid P, et al.
Cytokine Growth Factor Rev . 2012 Sep; 24(1):13-22. PMID: 22981349
Experiments in IL-15(-/-) and IL-15Rα(-/-) mice show that intra-renal IL-15, through IL-15Rα behaves as an epithelial survival factor. Recent data highlight new functions of IL-15 in renal homeostasis mediated by...
9.
Giron-Michel J, Azzi S, Khawam K, Mortier E, Caignard A, Devocelle A, et al.
PLoS One . 2012 Feb; 7(2):e31624. PMID: 22363690
The ability of Interleukin-15 (IL-15) to activate many immune antitumor mechanisms renders the cytokine a good candidate for the therapy of solid tumors, particularly renal cell carcinoma. Although IL-15 is...
10.
Azzi S, Bruno S, Giron-Michel J, Clay D, Devocelle A, Croce M, et al.
J Natl Cancer Inst . 2011 Nov; 103(24):1884-98. PMID: 22043039
Background: Many renal cancer patients experience disease recurrence after immunotherapy or combined treatments due to persistence of cancer stem cells (CSCs). The identification of reliable inducers of CSC differentiation may...